Fundraising Fox

Star51 Capital

Venture capitalActively deploying

New York · 16 people tracked

Fox Verdict
Sign up to see your fit

Investment thesis

Star51 Capital invests at the intersection of Medtech and AI, positioning itself as a bridge between innovation and acquisition. Backed by a leading healthcare system and a top-5 global Medtech strategic, the fund provides portfolio companies with clinical validation, commercialization pathways, and domain expertise in addition to capital. Managed by founders-turned-investors who have built, scaled, and exited Medtech companies, the firm sources high-conviction opportunities from the US, Europe, and Israel. Its integrated ecosystem model is designed to build startups that are attractive acquisition targets for strategic buyers.

Source: firm website, verified Aug 11, 2026.

HQ
New York, US
Instruments
Equity
Founded
2025
Last 12 months
1 investment
Tracked investments
1

Team · 16 people

from the firm's website
Anjan Chatterji· Serial Investor/Founder

Domain expert and venture partner; serial investor and founder.

Jessica Richter· Founder & CEO, RAC

Domain expert and venture partner; Founder and CEO of RAC.

Mark Gelfand· IP / Serial Founder

Domain expert and venture partner focused on IP; serial founder.

Scott Pantel· Founder & CEO, LSI

Operating Partner; Founder and CEO of LSI.

Henry Peck· CBO, LSI

Domain expert and venture partner; Chief Business Officer at LSI.

Howard Levin· Cardiovascular Expert, MD

Domain expert and venture partner focused on cardiovascular medicine.

Josh Defonzo· CEO, Mendaera

Domain expert and venture partner; CEO of Mendaera.

Ken Nelson· Commercial Leader

Domain expert and venture partner; commercial leader.

Michael Tutera· Market Access & Reimbursement

Domain expert and venture partner focused on market access and reimbursement.

Nir Goldenberg· Senior Dir Business Development, Mayo Clinic BD

Domain expert / venture partner; Senior Director of Business Development at Mayo Clinic BD.

Patrick Mitchell· Finance Expert

Domain expert and venture partner with finance expertise.

Joe Mullings· Chairman & CEO, The Mullings Group

Operating Partner; Chairman and CEO of The Mullings Group.

Raymond Cohen· Multi-exit CEO/Chairmanin

Operating Partner and multi-exit CEO/Chairman.

What they invest in

from 1 of 1 portfolio companies

Biotech ×1Healthtech ×1

HQs:United States×1

Investments · 1 tracked

founders shown can be your intro path
Microbot Medical Inc.NASDAQ: MBOTSep 2025SEC filingmedium confidence

BiotechHealthtechBraintree, US

Moshe Shoham(Director)Rachel Vaknin(Executive Officer)SIMON SHARON(Executive Officer)Juan Diaz-Cartelle(Executive Officer)David Ben Naim(Chief Financial Officer)Yehezkel Himelfarb(Chief Operating Officer)

Board seatTal Wenderow· per SEC Form D · $25.2M raise · filed Sep 2025

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Exits · 1

IPOs and acquisitions across the tracked portfolio

Microbot Medical Inc.NASDAQ: MBOT

Portfolio news

latest coverage across their companies

Frequently asked questions

What sectors does Star51 Capital focus on?
Star51 Capital focuses on AI & Machine Learning, Digital Health, Healthtech, Medical Devices.
Where is Star51 Capital located?
Star51 Capital is headquartered in New York, US.

Similar investors

Featured in lists